Concepedia

Akiko Toyota

AT

Statistics

Publications

3

Citations

73

H-Index

3

Active since

2019

Affiliations

Daiichi-Sankyo (Japan)(Current)

Daiichi Sankyo (Germany)

Akiko Toyota is an author at Daiichi-Sankyo (Japan) specializing in oncology, pharmacology, and drug discovery.

Publications per year

2019–2023

3

Publications

3

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1

Masashi Numata, Noriyasu Haginoya, Machiko Shiroishi et al. · Cancer Cell International · 2023 · 29 citations · Full text

Medicine, Oncology, Pharmacology +13

Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity

Toru Taniguchi, Hiroaki Inagaki, Daichi Baba et al. · ACS Medicinal Chemistry Letters · 2019 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +13

Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model

Akiko Toyota, Megumi Goto, Masaya Miyamoto et al. · Biochemical and Biophysical Research Communications · 2022 · 17 citations

Medicine, Oncology, Pharmacology +14

1–3 of 3